semaglutide news november 28 2025 Eli Lilly, Novo Nordisk near deals with Trump admin to cut weight loss drug prices Anti-Obesity Medications Set to Explode

In its submission to FDA, Eli Lilly and Company relied on these proposed criteria and claimed that tirzepatide, the active ingredient in Mounjaro (tirzepatide) injection and Zepbound (tirzepatide) injection, meets at least two of these proposed criteriafirst because of the complexity of its formulation, and second because of the complexity in its required physiochemical or analytical testing

-Compounding pharmacies are not required to report adverse events that occur with their products

Dehydration can happen quickly

Lightweight and fast-absorbing, this serum layers seamlessly into your routine without stickiness, delivering both immediate hydration and long-term brightening effects

While these changes may support weight loss, they can create new dental risks